Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dapagliflozin After Transcatheter Aortic Valve Implantation

NCT04696185 is registered in ClinicalTrials.gov with Spanish Society of Cardiology as lead sponsor.

NCT NCT04696185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04696185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dapagliflozin After Transcatheter Aortic Valve Implantation
Lead sponsor
Spanish Society of Cardiology
Phase
Phase 4
Overall status
Completed
Start date
January 27, 2021
Completion date
December 30, 2024
Enrollment
1,257 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, transcatether aortic valve implantation